Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination in Glaucoma or Ocular Hypertension
NCT00961649Phase 2Terminated
- Sponsor
- Alcon Inc.
- Start
- Oct 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of brinzolamide, brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2009; status: terminated.
02
Drugs
brinzolamidebrimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00961649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00961649.